CVS Health (CVS) Mentioned Positive at Cleveland Research
- Wall Street ends lower as investors await earnings, inflation data
- Microsoft (MSFT) announces $19.7 billion acquisition of Nuance (NUAN)
- Alibaba (BABA) Gets a Record $2.8 Billion Anti-Monopoly Fine, Shares Soar as a 'Major Overhang' is Lifted
- Tesla (TSLA) Upgraded to 'Buy' at Canaccord Genuity and PT Raised by 155%, as it 'Holds a Several-Year Lead' in EV While Storage Business Accelerates
- Dollar drops as traders prepare for inflation data
News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.
CVS Health (NYSE: CVS) mentioned positively at Cleveland Research, saying checks indicate 2021 has a number of Rx tailwinds. They see upside to the current consensus.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- CVS Health to Administer No-Cost COVID-19 Vaccines at 11 Select CVS Pharmacy Locations in Nebraska
- CVS Health to Administer No-Cost COVID-19 Vaccines at 16 Select CVS Pharmacy Locations in Arkansas
- Aristocrat Leisure (ALL:AU) (ARLUF) PT Raised to AUD37.48 at Goldman Sachs
Create E-mail Alert Related CategoriesAnalyst Comments
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!